Editor's key pointsAs global access to surgical procedures increases, it is important to understand differences in outcomes depending on economic development and access to perioperative care.The International Surgical Outcomes Study evaluated incidence and risk factors for complications and death after inpatient elective surgery in 27 countries of varied economic status.Adverse outcomes were common after inpatient surgery and were similar in low- and middle-income compared with high-income countries despite lower baseline risk of the former.

About 310 million patients undergo surgery worldwide each year, with more procedures taking place in high-income countries.[@aew316-B1] [@aew316-B2] Findings from epidemiological studies suggest that 4.8 billion people are unable to access safe surgical treatments,[@aew316-B3] and that at least 143 million additional procedures are required each year, primarily in low- and middle-income countries.[@aew316-B4] [@aew316-B5] However, as health care systems develop to improve access to surgical treatments, the number of patients who suffer postoperative complications will also increase.[@aew316-B3] [@aew316-B4]

Postoperative complications increase treatment costs[@aew316-B6] and reduce both life expectancy and quality of life.[@aew316-B7] [@aew316-B8] Nonetheless, our global understanding of outcomes after surgery remains limited. Estimates from high-income countries suggest postoperative complications occur in up to 20% of patients,[@aew316-B9] [@aew316-B10] and short-term mortality varies from 1 to 4%.[@aew316-B11] While effective perioperative care is considered essential to the safe provision of surgical treatments,[@aew316-B8] the optimal level of such care has not been defined. Admission to a critical care unit is often considered necessary to prevent or treat life-threatening complications. However, this level of patient care is very expensive and there is little or no evidence to confirm the critical care resource provision needed for a safe surgical service.

As we seek to ensure the global availability of surgical treatments to all patients, we need to understand how often patients develop complications after surgery, the severity of harm that results, and how hospital systems should be configured to safely respond. We performed the International Surgical Outcomes Study (ISOS) to evaluate the global incidence and risk factors for complications and death after inpatient elective surgery and to describe current standards of postoperative care.

Methods
=======

Project organisation
--------------------

ISOS was a 7-day international cohort study. Regulatory requirements differed between countries, with some requiring research ethics approval and some requiring only data governance approval. In the UK, the study was approved by the Yorkshire & Humber Research Ethics Committee (reference: 13/YH/0371). The inclusion criteria were all adult patients (age ≥18 years) undergoing elective surgery with a planned overnight stay in the hospital. Each participating country selected a single data collection week between April and August 2014. Patients undergoing emergency surgery, day-case surgery or radiological procedures were excluded. Patient data included only that recorded as part of routine care. In some countries, patient consent was sought to allow the collection of [supplementary data](http://bja.oxfordjournals.org/lookup/suppl/doi:10.1093/bja/aew316/-/DC1) for prespecified substudies. In each country we approached individuals to act as national coordinators using contacts in national and international specialist societies in surgery and anaesthesia. Individual participating hospitals were then identified through a global online recruitment campaign led by the study management group and through the direct approach of the national coordinators. Nominations for participation were then confirmed as appropriate through discussion with national coordinators. The study website provided all study documentation and guidance on study procedures ([www.isos.org.uk/documents](http://www.isos.org.uk/documents)). ISOS was registered prospectively with an international trial registry (ISRCTN51817007).

Data collection
---------------

Data describing perioperative care facilities were collected for each hospital at the beginning of the study. Data describing consecutive patients were collected until hospital discharge on paper case record forms (Supplementary file). Complications were assessed according to predefined criteria and graded as mild, moderate, or severe.[@aew316-B19] Data were censored at 30 days following surgery for patients who remained in the hospital. Data were anonymised before entry onto a secure Internet-based electronic case record form designed specifically for ISOS, which incorporated automated checks for plausibility, consistency and completeness.

Outcome measures
----------------

The primary outcome measure was in-hospital postoperative complications. Secondary outcomes were death following a postoperative complication (failure to rescue) and in-hospital mortality. Process measures were admission directly to critical care after surgery, admission to critical care for treatment of a postoperative complication, and duration of hospital stay. A single prospective definition of critical care was used for all countries (a facility routinely capable of admitting patients who require invasive ventilation overnight).

Statistical analysis
--------------------

We aimed to recruit as many hospitals and countries as possible and asked investigators in those hospitals to enrol all eligible patients. No formal sample size calculation was performed. Only hospitals returning valid data describing ≥10 patients and countries with ≥10 participating hospitals were included in the primary analysis.

Association between surgical procedure category and patient outcomes
--------------------------------------------------------------------

We assessed the association between surgical procedure category and complications or mortality both before and after adjustment for potential confounding factors. The unadjusted analysis was performed using a logistic regression model with the surgical procedure category included as a fixed factor. The adjusted analysis was performed using a three-level mixed-effects logistic regression model. Patients were entered at the first level, hospitals at the second level, and countries at the third level. This model accounted for correlation between patients in the same hospital or country. The following variables were included as fixed factors in the model: age, current smoker, American Society of Anesthesiologists (ASA) physical status score, severity of surgery, surgical procedure category, and presence of ischaemic heart disease, heart failure, diabetes mellitus, chronic obstructive pulmonary disease/asthma, cirrhosis, stroke, or other comorbid diseases. Factors were selected for biological plausibility, scientific rationale, and a low rate of missing data. We used restricted cubic splines to account for a potential non-linear association between age and outcome.[@aew316-B20] To assess the effect of predefined exclusions on our findings, we repeated our analyses for all patients in the database. For both the unadjusted and adjusted analyses, Hosmer--Lemeshow goodness-of-fit statistics were used to test model calibration and multicollinearity was assessed using the variance inflation factor. The ability of the model to discriminate cases from non-cases was assessed using the area under the receiver operating characteristic curve (AUROC). Data are presented as mean ([sd]{.smallcaps}) and median \[interquartile range (IQR)\] for continuous data, number (%) for binary data, or odds ratios (ORs) with 95% confidence intervals (CIs). Analyses were performed using Stata 14 (StataCorp, College Station, TX, USA).

Results
=======

Data describing 44 814 patients were collected from 474 hospitals in the following countries and regions: Australia, Austria, Belgium, Brazil, Canada, China, Denmark, France, Germany, Greece, Hong Kong, Indonesia, Italy, Malaysia, The Netherlands, New Zealand, Nigeria, Portugal, Romania, Russia, South Africa, Spain, Sweden, Switzerland, Uganda, UK, and USA ([Fig. 1](#aew316-F1){ref-type="fig"}). Fewer than 10 hospitals participated in India, Iraq, and Mexico, and in accordance with the prospective statistical analysis plan, patients recruited in these countries were excluded from the primary analysis ([Fig. 2](#aew316-F2){ref-type="fig"}). Seven countries were classed as middle income and one as low income, with 134 participating hospitals between them.[@aew316-B21] Hospitals had a median of 550 (range 329--850) ward beds and 21 (range 10--38) critical care beds. The median critical care capacity (ratio of critical care beds to total hospital beds) was 4% (IQR 2--6). A total of 310 hospitals (66%) were affiliated with a university. Seventy-seven percent of hospitals provided only government funded health care, 3% only privately funded health care, and 21% were funded by both sources. Baseline patient data are presented in [Table 1](#aew316-T1){ref-type="table"}. Table 1.Baseline patient characteristics. All data presented as *n* (%) unless otherwise noted. ASA, American Society of Anesthesiologists; COPD, chronic obstructive pulmonary disease**All patients(*n*** **=** **44 814)Patients with complications(*n*** **=** **7508)Patients with nocomplications (*n*** **=** **37 306)Patients whodied (*n*** **=** **207)Patients who survived(*n*** **=** **44 607)**Age, years, mean ([sd]{.smallcaps})55.3 (17.1)61.8 (16.0)54.1 (17.0)69.1 (13.3)55.3 (17.1)Age, years, median (range)57 (18--102)64 (18--100)55 (18--102)73 (28--93)57 (18--102)Male20 458 (45.7)3968 (19.4)16 490 (80.6)121 (0.6)20 337 (99.4)Smoker7913 (17.8)1305 (16.5)6608 (83.5)47 (0.6)7866 (99.4)**ASA score**I11 227 (25.1)848 (7.6)10 379 (92.5)1 (0.1)11 226 (99.9)II22 265 (49.8)3005 (13.5)19 260 (86.5)38 (0.2)22 227 (99.8)III10 193 (22.8)3090 (30.3)7103 (69.7)115 (1.1)10 078 (98.9)IV1038 (2.3)554 (53.4)484 (46.6)53 (5.1)985 (94.9)**Severity of surgery**Minor8411 (18.8)672 (8.0)7739 (92.0)14 (0.2)8397 (99.8)Intermediate20 203 (45.1)2494 (12.3)17 709 (87.7)56 (0.3)20 147 (99.7)Major16 175 (36.1)4336 (26.8)11 839 (73.2)137 (0.9)16 038 (99.1)**Surgical procedure**Orthopaedic9459 (21.1)1556 (16.5)7893 (83.5)25 (0.3)9434 (99.7)Breast1538 (3.4)128 (8.3)1410 (91.7)2 (0.1)1536 (99.9)Obstetrics and gynaecology5674 (12.7)554 (9.8)5120 (90.2)6 (0.1)5668 (99.9)Urology and kidney4871 (10.9)720 (14.8)4151 (85.2)10 (0.2)4861 (99.8)Upper gastrointestinal1986 (4.4)485 (24.4)1501 (75.6)29 (1.5)1957 (98.5)Lower gastrointestinal3073 (6.9)748 (24.3)2325 (75.7)32 (1.0)3041 (99.0)Hepatobiliary2282 (5.1)366 (16.0)1916 (83)14 (0.6)2268 (99.4)Vascular1599 (3.6)410 (25.6)1189 (74.4)15 (0.9)1584 (99.0)Head and neck6510 (14.5)674 (10.4)5836 (89.6)12 (0.2)6498 (99.8)Plastics and cutaneous1670 (3.7)244 (14.6)1426 (85.4)5 (0.3)1665 (99.7)Cardiac1716 (3.8)979 (57.0)737 (43.0)40 (2.3)1676 (97.7)Thoracic1157 (2.6)305 (26.4)852 (73.6)10 (0.9)1147 (99.1)Other3270 (7.3)328 (10.0)2942 (90.0)7 (0.2)3263 (99.8)**Comorbid disease**Ischaemic heart disease4588 (10.3)1525 (33.2)3063 (66.8)67 (1.5)4521 (98.5)Heart failure1882 (4.2)775 (41.2)1107 (58.8)49 (2.6)1833 (97.4)Diabetes mellitus5171 (11.6)1319 (25.5)3852 (74.5)58 (1.1)5113 (98.9)Cirrhosis342 (0.8)113 (33.0)229 (67.0)10 (2.9)332 (97.1)Metastatic cancer1706 (3.8)508 (29.8)1198 (70.2)36 (2.1)1670 (97.9)Stroke1492 (3.3)451 (30.2)1041 (69.8)38 (2.6)1454 (97.4)COPD/asthma4094 (9.2)1012 (24.7)3082 (75.3)40 (1.0)4054 (99.0)Other18 607 (41.6)4134 (22.2)14464 (77.8)134 (0.7)18473 (99.3)**Other measures**Laparoscopic surgery7087 (15.8)905 (12.8)6182 (87.2)16 (0.2)7071 (99.8)Cancer surgery9006 (20.3)2005 (22.2)7001 (77.7)70 (0.8)8936 (99.2) Fig 1.Countries participating in the International Surgical Outcomes Study. Blue: countries included in the primary analysis. Green: countries with \<10 participating hospitals included in the secondary analysis. Fig 2.Patients, hospitals, and countries excluded from the study.

Data validation
---------------

There was high concordance in a random 1% data sample selected for duplicate entry (95% for categorical variables, 92% for continuous variables), with very high concordance for clinical outcomes (99.7%). Investigators were granted immediate access to their uncleaned data once this was locked following entry and were encouraged to review it for accuracy and completeness. All national coordinators confirmed the face validity of the baseline and crude outcome data for their countries. Only a small proportion of patients \[451/44 814 (1%)\] were missing data for at least one of the factors included in the model. Due to the low proportion of missing data, we performed a complete case analysis where patients with missing data were excluded from the analysis ([Supplementary Table 1](http://bja.oxfordjournals.org/lookup/suppl/doi:10.1093/bja/aew316/-/DC1)). Hosmer--Lemeshow goodness-of-fit statistics indicated that the models were well calibrated, with a good match between observed and expected outcomes. Discrimination of the model was good, with an AUROC of 0.80 (95% CI 0.80--0.81). Residuals showed that the assumptions for regression analyses were met. All variables had a variance inflation factor of \<5.

Clinical outcomes
-----------------

A total of 7508 (16.8%) patients developed complications in the hospital and 207 died before hospital discharge (0.5%), indicating an overall mortality among patients who developed complications (failure to rescue) of 2.8%. A total of 5254 (11.7%) patients developed a single postoperative complication, while another 2254 (5.0%) patients developed two or more complications. The breakdown of complications is presented in [Table 2](#aew316-T2){ref-type="table"}. Infectious complications were the most frequent, in particular superficial surgical site infections. A total of 2925 patients developed an unspecified complication ('other' category). There were significant variations in complications and mortality across surgical procedure categories and countries ([Fig. 3](#aew316-F3){ref-type="fig"}, [Supplementary Tables 2 and 3](http://bja.oxfordjournals.org/lookup/suppl/doi:10.1093/bja/aew316/-/DC1)). Outcomes for patients according to planned admission to critical care immediately after surgery are presented in [Table 3](#aew316-T3){ref-type="table"}. A total of 1233 patients (16.4%) were admitted to a critical care unit to treat complications, of whom 119 (9.7%) died. Fifty-eight (28.0%) patients who died were not admitted to critical care at any stage during their admission, either immediately after surgery or for treatment of a complication. The clinical outcomes for all patients included in the database are presented in [Supplementary Table 4](http://bja.oxfordjournals.org/lookup/suppl/doi:10.1093/bja/aew316/-/DC1). Table 2.Postoperative complications and mortality for 44 814 patients undergoing elective surgery. Data presented as *n* (%). ARDS, acute respiratory distress syndrome; N/A, category not applicable for this complication. Some patients may have developed more than one complication and consequently, in some cases, the denominator is the number of complications while in the left-most column the denominator is the number of patients. The cell at the bottom of the far right column represents the number of deaths divided by the number of patients with at least one complicationSeverity of complicationsMortality for patients whodeveloped complications***N*** **=** **44 814**MildModerateSevere***N*** **=** **207Infectious complications**Superficial surgical site1320 (2.9)681/1320 (51.6)517/1320 (39.2)122/1320 (9.2)17/1320 (1.3)Deep surgical site566 (1.3)120/566 (21.2)250/566 (44.2)196/566 (34.6)28/566 (4.9)Body cavity340 (0.8)97/340 (28.5)136/340 (40.0)107/340 (31.5)24/340 (7.0)Pneumonia708 (1.6)240/708 (33.9)325/708 (45.9)143/708 (20.2)55/708 (7.8)Urinary tract681 (1.5)294/681 (43.2)333/681 (48.9)54/681 (7.9)13/681 (1.9)Bloodstream417 (0.9)140/417 (33.6)162/417 (38.8)115/417 (27.6)48/417 (11.5)Total infectious complications40321572/4032 (39.0)1723/4032 (42.7)737/4032 (18.3)104/4032 (2.6)**Cardiovascular complications**Myocardial infarction139 (0.3)45/139 (32.4)43/139 (30.9)51/139 (36.7)26/139 (18.7)Arrhythmia1222 (2.7)468/1222 (38.3)568/1222 (46.5)186/1222 (15.2)74/1222 (6.1)Pulmonary oedema330 (0.7)127/330 (38.4)141/330 (42.8)62/330 (18.8)34/330 (10.3)Pulmonary embolism78 (0.2)17/78 (21.8)33/78 (42.3)28/78 (35.9)5/78 (6.4)Stroke111 (0.2)31/111 (27.9)28/111 (25.2)52/111 (46.9)18/111 (16.2)Cardiac arrest153 (0.3)N/AN/A153/153 (100.0)91/153 (59.5)Total cardiovascular complications2033688/2033 (33.8)813/2033 (40.0)532/2033 (26.2)141/2033 (6.9)**Other complications**Gastrointestinal bleed201 (0.4)95/201 (47.3)66/201 (32.8)40/201 (19.9)24/201 (11.9)Acute kidney injury778 (1.7)423/778 (54.4)203/778 (26.1)152/778 (19.5)76/778 (9.8)Postoperative bleed1362 (3.0)N/A1147/1362 (84.2)215/1362 (15.8)55/1362 (4.0)ARDS142 (0.3)46/142 (32.4)41/142 (28.9)55/142 (38.7)34/142 (23.9)Anastomotic leak208 (0.5)52/208 (25.0)62/208 (29.8)94/208 (45.2)21/208 (10.1)All others2934 (6.5)1342/2925 (45.9)1200/2925 (41.0)392/2925 (13.4)83/2925 (2.8)Total other complications56251958/5625 (34.8)2719/5625 (48.3)948/5625 (16.9)158/5625 (2.8)Total number of complications11 6904218/11 690 (36.1)5255/11 690 (45.0)2217/11 690 (19.0)207/7508 (2.8) Table 3.Outcomes for patients according to planned admission to critical care immediately after surgery. Data presented as *n* (%)All patients(*n* = 44 814)Patients admittedto critical care immediatelyafter surgery (*n* = 4360)Patients not admittedto critical care immediatelyafter surgery (*n* = 39 935)**Mortality**207/44 814 (0.5)105/4360 (2.4)99/39 935 (0.2)**Complication(s)**7508/44 814 (16.8)2198/4360 (50.4)5270/39 935 (13.2)**Critical care admission to treat complication(s)**1233/7508 (16.4)857/2198 (39.0)365/5270 (6.9)**Death following a complication (failure to rescue)**207/7508 (2.8)105/2198 (4.8)99/5270 (1.9) Fig 3.Adjusted risk (odds ratio) of complications with 95% confidence intervals and in-hospital mortality in different surgical procedure categories.

Process measures
----------------

The median stay in a post-anaesthetic care unit was 1 (IQR 0--2) h. A total of 4360 (9.7%) patients were admitted to a critical care unit as routine immediately after surgery. The median length of time spent in critical care for those with a planned admission directly after surgery was 1 (IQR 1--3) day. Of these patients, 2198 (50.4%) developed a complication, with 105 (2.4%) deaths. A total of 1233 (4.9%) patients were admitted to a critical care unit to treat complications, of whom 119 (9.7%) died. The median length of time spent in critical care for patients admitted to treat a complication was 3 (IQR 1--6) days. The median overall hospital stay was 4 (IQR 2--7) days, increasing to 8 (IQR 5--14) days among those patients who developed complications.

Outcomes in low-, middle-, and high-income countries
----------------------------------------------------

Patient outcomes and process measures according to low- and middle- or high-income country status are presented in [Table 4](#aew316-T4){ref-type="table"}. One country in the low- and middle-income groups, which returned a large patient sample, experienced much lower complication rates than other participating nations. Patients in low- and middle-income countries tended to be younger with lower ASA scores. Crude complication rates were lower, but mortality rates overall, and for patients developing complications, were similar to those in high-income countries, suggesting care for patients who develop complications may be less effective. There was a much lower rate of planned admission to critical care immediately after surgery in low- and middle-income countries. Table 4.Hospital resources, process measures and patient outcomes in low-, middle-, and high-income countries**Low- and middle-income countries (*n*** **=** **8)High-income countries (*n*** **=** **19)Number of hospitals**126348**Number of patients**15 80629 008**Hospital characteristics, median (IQR)Total beds per hospital**825 (412--1318)570 (361--835)**Critical care beds per hospital**25 (12--45)20 (11--37)**Critical care capacity per hospital**2.8% (1.5--4.8)3.6% (2.4--5.9)**Patient characteristicsAge, years, mean ([sd]{.smallcaps})**50.8 (16.0)57.8 (17.2)**ASA I and II, *n* (%)**13 766 (87.2)19 726 (68.2)**ASA III and IV, *n* (%)**2029 (12.8)9202 (31.8)**Comorbid disease (any), *n* (%)**6488 (41.2)19 590 (67.6)**Metastatic cancer, *n* (%)**297 (1.9)1409 (4.9)**Process measuresPost-anaesthetic care unit stay (h), median (IQR)**1 (0--1)1 (1--2)**Length of hospital stay (days), median (IQR)**5 (3--8)3 (1--6)**Planned critical care admission, *n* (%)**1051/15 299 (6.9)3309/28 996 (11.4)**Critical care to treat complication(s) , *n* (%)**317/15 806 (2.0)916/28 905 (3.2)**Patient outcomes, *n* (%)Complication(s)**1760/15 806 (11.1)5748/29 008 (19.8)**Mortality**58/15 806 (0.4)149/29 008 (0.5)**Mortality following complications**58/1760 (3.3)149/5748 (2.6)

Discussion
==========

This international prospective cohort study has provided detailed outcome data on a population of \>44 000 consecutive patients undergoing elective inpatient surgery in 27 low-, middle-, and high-income countries worldwide. The principal finding was that 1 in 6 patients experienced a complication before hospital discharge and 1 in 35 patients who experienced a complication subsequently died without leaving the hospital. The mortality among patients who developed complications (failure to rescue) of 2.8% indicates the continued need for a more effective treatment response for patients who develop postoperative complications. Despite lower baseline risk, crude patient outcomes were broadly similar in low- and middle-income compared with high-income countries.

There are few large datasets of complication rates after surgery, and none we are aware of which provide data at an international level, although the findings of a recent study of almost 11 000 patients undergoing emergency abdominal surgery in 58 low-, middle-, and high-income countries indicate high mortality following such procedures.[@aew316-B22] Caution should be exercised when comparing between country-level datasets because of international differences in patterns of surgical disease and genetic backgrounds, as well as in health care systems. A variable degree of selection bias is also likely to result in important differences between reports that are few in number. While overall complication rates in the current data were slightly lower than those previously reported in the USA,[@aew316-B9] [@aew316-B23] this might simply be due to differences in patient risk factors and the surgical procedures included. In particular, ISOS only included patients undergoing elective surgery. Previous mortality estimates for unselected patient populations undergoing inpatient surgery vary between 1 and 4%.[@aew316-B15] A recent study of postoperative mortality in Europe suggested in-hospital mortality of 3% for elective inpatient surgery,[@aew316-B11] similar to overall mortality rates in reports from the USA.[@aew316-B9] [@aew316-B16] [@aew316-B23]

These data provide detailed insights into patterns of critical care admission after surgery. This is an expensive resource, and rates of admission in low- and middle-income countries appear to be much lower than in high-income countries. The value of routine admission of high-risk patients to a critical care unit after surgery remains uncertain and allocation of this resource appears inconsistent. For example, admission to critical care after cardiac surgery is routine in most countries, while high-risk patients undergoing non-cardiac surgery may not be provided with this level of care despite a much higher mortality rate.[@aew316-B12] The findings of two recent health care registry studies in the UK suggest that provision of critical care can improve survival for surgical patients, although the effect may be subtle.[@aew316-B24] [@aew316-B25] Meanwhile, a study of Medicare registry data in the USA failed to identify any benefit of critical care admission.[@aew316-B26] [@aew316-B27] Comparison of failure to rescue (rate of death after postoperative complications) between hospitals and health care systems could help us to understand the impact of postoperative critical care on patient outcomes. While it seems unlikely that we could ever reduce mortality from postoperative complications to zero, failure to rescue has provided a useful metric of the quality of postoperative care for surgical patients in high-income countries.[@aew316-B9] [@aew316-B28] We could argue that in a well-resourced system, very few patients should die after elective surgery without being admitted to a critical care unit. The current data confirm there is an important rate of failure to rescue at a global level, which is placed in context by the rates of use of critical care facilities. Global strategies to improve access to surgical treatments should take account of the increased demand for perioperative care services, in particular critical care, for patients who develop complications.[@aew316-B3] [@aew316-B4] While the surgical population is very large, few countries have any reliable system to monitor the volume of activity and clinical outcomes. Understanding the safety and effectiveness of surgical treatments is therefore limited and the need remains for robust audit and public reporting of outcomes after all surgery worldwide.[@aew316-B8] Data-driven improvement in the quality of perioperative care might be possible even in resource-limited environments.[@aew316-B32]

A strengths of this study is the large number of consecutive patients enrolled worldwide. Importantly, critical care beds were classified according to a standard definition in participating hospitals. We also distinguished between planned admission to critical care immediately after surgery as a part of routine postoperative management and unplanned admission to critical care to treat a life-threatening complication. By developing a very simple dataset consisting primarily of categorical variables, we were able to minimise the amount of missing data. Patient-level variables were selected on the basis that they were objective, routinely collected for clinical reasons, could be transcribed with a high level of accuracy, subject to a low rate of missing data, and relevant to a risk adjustment model that included a wide variety of surgical procedures. The online data entry system was designed specifically for ISOS and included a variety of internal error checks while avoiding the redundant functionality of generic software designed for complex trials.

The study also has a number of weaknesses. Despite the large sample size, we cannot consider this study as representative of current practice in all countries. ISOS was a pragmatic study and only a small proportion of hospitals took part in a small number of countries. While we are pleased to have recruited hospitals in 30 countries, only 27 of these reached the predefined number of participating hospitals. We discussed participation with potential investigators in a number of countries who did not feel they had adequate resources to take part. This affected the participation of low-, middle-, and high-income countries. Many patients were enrolled in university hospitals while smaller, low-volume centres are underrepresented. This effect was greater in the low- and middle-income countries that took part. The risk adjustment methods used might not fully account for high mortality rates in hospitals specialising in more complex surgery. After risk adjustment there were differences in postoperative outcomes between countries, but there are likely to be differences in case mix that are not fully represented in our baseline data.[@aew316-B12] We note that crude complication and mortality rates were lower in one high-volume country, reducing the overall event rate. Given the pragmatic nature of this study, it was only possible to follow patients until hospital discharge. In countries where the availability of hospital beds is more limited, early hospital discharge of patients could have resulted in a lower measured complication rate. Although we planned to enrol every eligible patient undergoing surgery during the study period, we cannot be sure of the exact proportion of eligible patients included. Despite these limitations, assuming the volume of surgery during the cohort week is typical of the participating hospitals, these centres perform \>3 million inpatient surgical procedures each year, ∼1% of the estimated volume of surgery taking place worldwide.[@aew316-B12]

Conclusions
===========

The findings of this international cohort study indicate that a large number of patients develop complications after elective inpatient surgery. Global strategies to improve access to surgical treatments should take account of the increased demand placed on perioperative care services.
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